1st Poseidon's World Conference: The low prognosis patient in ART
9-10 september · Lisbon, Portugal

Overview

Management of patients with an impaired ovarian reserve or poor ovarian response (POR) to exogenous gonadotropin stimulation has challenged reproductive specialists for years. Apart from the limited understanding of its pathophysiology, there is wide heterogeneity in defining POR and overall disappointing outcomes in assisted reproductive technology (ART) cycles.

The First POSEIDON’s World Conference will dissect the new POSEIDON criteria as a means to improve the management of patients exposed to assisted reproductive technology. The new criteria enable discussion of novel approaches catered specifically to patients with low prognosis during IVF, thereby offering better tools to optimise IVF success rates.

The program will engage renowned international experts with vast clinical experience in constantly evolving subjects. The program aims to impart specific knowledge with focus on changing concepts or practices.

Learning Objectives

Target Audience

The program is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.

Accreditation

This program has been accredited by the SWISS GYNECOLOGY SGGG with 12 CME credits and CPD Certification Service, UK. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. 

 

This program has been submitted for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME®).

 

Educational Resources

Previous Research Topic with 22 articles, downloadable as an eBook:
POSEIDON’s Stratification of “Low Prognosis Patients in ART”: The WHY, the WHAT, and the HOW

1st Poseidon's World Conference: The low-Prognosis patient in ART

9-10 September . Lisbon, Portugal

Scientifc program

Check the agenda below

Accreditation

This program has been accredited by the SWISS GYNECOLOGY SGGG with 12 CME credits and CPD Certification Service, UK. and has been submitted for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME®).

Language

The official language of the activity will be English.

Venue

Estoril Convention Center Avenida Amaral. 2765-192 Estoril Cascais, Portugal

Chairs

Carlo Alviggi

Naples, Italy
Biography

Sandro C. Esteves

Campinas, Brazil
Biography

Robert Fisher

Hamburg, Germany
Biography

Peter Humaidan

Aarhus, Denmark
Biography

Pedro Xavier

Porto, Portugal
Biography

National Scientific Committee

Centro de Medicina da Reprodução – Ferticare

Braga, Portugal

Centro Hospitalar Do Porto

Centro Materno Infantil Do Norte

Porto , Portugal

Universidade de Coimbra

Facultade de Medicina

Coimbra, Portugal

AVA Clinic

Lisbon, Portuga

Centre for Reproductive Genetics Alberto Barros

Porto, Portugal

Hospital Lusíada

Lisbon, Portugal

Hospital Lusíadas

Lisbon, Portugal

International Scientific Committee

University Hospital of Copenhagen

Copenhagen, Denmark

MUHC Reproductive Center

McGill University

Montreal, QC, Canada

Rio de Janeiro State University

Vida Fertility Center

Rio de Janeiro, Brazil

Ginefiv-GeneraLife

Madrid, Spain

IVF Center Polyclinic Ibn Annafis – Sfax  –  Tunisia 

Fertility Group of the STGO  (Tunisian Society of obstetrics and gynecology)

Sfax, Tunisia

GENESIS – Center for Assistance in Human Reproduction

SBRA – Brazilian Society of Assisted Reproduction

Brasilia, Brazil

Tiziri IVF Center

Algeriers, Algeria

King’s College London

London, UK

G.E.N.E.R.A. Centre for Reproductive Medicine

Rome, Italy

Edith Wolfson Medical Center

Sackler Faculty of Medicine, Tel-Aviv University

Tel-Aviv, Israel

Medicine Universitas Indonesia

Yasmin IVF Clinic

Jakarta, Indonesia

Anatolia IVF and Women’s Health Center

Ankara, Turkey

Faculty

Carlo Alviggi

Naples, Italy
Biography

Claus Yding Andersen

University Hospital of Copenhagen Copenhagen, Denmark
Biography

Klaus Bühler

Centre for Reproductive Medicine & Gynaecological Endocrinology
Stuttgart, Germany
Biography

Alessandro Conforti

Federico II University
Naples, Italy
Biography

Michael Dahan

MUHC Reproductive Center
McGill University
Montreal, QC, Canada
Biography

Sandro C. Esteves

Campinas, Brazil
Biography

Robert Fisher

Hamburg, Germany
Biography

Joaquín Llacer

Ginefiv-GeneraLife Madrid, Spain
Biography

Antonio La Marca

Mother, Child and Adult
University of Modena and Reggio Emilia
Modena, Italy
Biography

Habib Midassi

IVF Center Polyclinic Ibn Annafis
Fertility Group of the STGO (Tunisian Society of obstetrics and gynecology)
Sfax, Tunisia
Biography

Maria Giulia Minasi

LaVitaMinaSi
Rome, Italy
Biography

Raoul Orvieto

Tel-Aviv University
Tel-Aviv, Israel
Biography

Amina Oumeziane

Tiziri IVF Center Algeriers, Algeria
Biography

Nina Papathanasopoulou

College Year in Athens Athens, Greece
Biography

Valerie Peddie

Aberdeen Maternity Hospital
Aberdeen, Scotland
Biography

Filippo Maria Ubaldi

G.E.N.E.R.A. Centre for Reproductive Medicine
Rome, Italy
Biography

Margarida Silvestre

Institute of Bioethics
University of Coimbra
Coimbra, Portugal
Biography

Sesh K. Sunkara

King’s College London
London, UK
Biography

Ariel Weissman

Edith Wolfson Medical Center
Sackler Faculty of Medicine, Tel-Aviv University
Tel-Aviv, Israel
Biography

Budi Wiweko

University of Indonesia
Yasmin IVF Clinic
Jakarta, Indonesia
Biography

Pedro Xavier

Hospital Lusíadas Lisbon, Portugal
Biography

Hakan Yarali

Anatolia IVF and Women’s Health Center
Ankara, Turkey
Biography

Scientific program

Agenda

Registration information

The Med.E.A. First POSEIDON’s World Conference (9-10 September 2022) will be held one day after the International Meeting of Reproductive Medicine Societies (8 September). A reduced fee will be offered if you would like to attend both conferences.

Click here to find out more information on the International Meeting of Reproductive Medicine Societies to be held on 8 September 2022. 

Registration Fee

Please select the type on the registration.

 

275* € Med.E.A. Medical Education Academy First POSEIDON World Conference + International Meeting of Reproductive Society
 


225€* Med.E.A. Medical Education Academy First POSEIDON World Conference

180€* First POSEIDON World Conference

You are eligiable for a reduced fee if you are a POSEIDON member.

www.groupposeidon.com

*+ 23% VAT 


The registration includes:

Scientific sessions

Coffee breaks and  lunch

Educational materials,

Certificate of attendance

Dinner is not included

 

> Register for free to the live streaming

General Information

Partnership

This program is designed in partnership with:

POSEIDON – Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number 

CME Provider

Med.E.A – Medical Education Academy

Chloe Xilinas: Program and Relations Manager in Medical Education

Funding

Our educational activities are supported by an independent grant from the Healthcare business of Merck KGaA, Darmstadt, Germany; and additional support from FUJIFILM EUROPE GMBH, Fujifilm Italia S.p.A., FUJIFILM France S.A.S.

· Carlo Alviggi ·

Carlo Alviggi earned his MD degree in 1994, from the Faculty of Medicine of the University of Naples “Federico II” in Naples, Italy; he specialized in obstetrics and gynaecology in 1998, and gained a PhD in 2001, from the same university. During his career, he collaborated with: The Imperial College of London, in London, UK; the Laboratory of Immunology of the Italian National Research Council in Naples; and the Autoimmunity and Tolerance Laboratory of the University of California in Los Angeles, CA, USA. This network resulted in various publications, some of which concern new hypotheses on the pathogenesis of pelvic endometriosis. He is now an associate professor in reproductive medicine at the Fertility Unit of the University of Naples “Federico II”. Professor Alviggi’s current research interests are the role of luteinizing hormone (LH) in folliculogenesis; the use of LH-containing drugs in patients undergoing ovarian controlled stimulation for IVF; the pathogenesis of pelvic endometriosis; oncofertility; reproductive endocrinology; and the genetics of human reproduction. He has participated in several national and international (phase 2 and 3) multicentric, prospective randomized trials. Professor Alviggi has published extensively and has been invited to lecture at over 100 international meetings dealing with reproductive medicine and gynaecological endocrinology; he has also served as an ad hoc reviewer for international journals in these fields.

· Sandro C. Esteves ·

Sandro Esteves, MD., Ph.D. is a board-certified urologist and consultant in assisted reproduction with over 25 years of clinical experience in all areas of reproductive medicine, with specialization in male reproduction.

He is listed by Expertscape among the top three world experts in the areas of male infertility, azoospermia, varicocele, and sperm retrieval techniques. Sandro has been also included in the list of the world’s most influential scientists.

He is the Founder and Medical Director of the ANDROFERT Andrology & Human Reproduction Clinic, in Campinas, Brazil. Dr. Esteves established the first Brazilian Fertility Clinic with a primary focus on male infertility, as well as the very first to introduce quality management as per the ISO 9001 standards and IVF cleanroom technology (ISO 14644-1).

Sandro is also a Collaborating Professor of Urology at the University of Campinas (UNICAMP, Brazil) and Honorary Professor of Reproductive Medicine at Aarhus University (Denmark). Dr. Esteves received his Master’s in Surgery from the University of Campinas Medical School and his Ph.D. in Urology from the Federal University of São Paulo Medical School. His post-doctoral training was at the American Center for Reproductive Medicine at the Cleveland Clinic in the United States. He has received many research grants and awards from national and international societies.

Prof. Esteves is the author of 10 textbooks in the fields of infertility and reproductive medicine. He was also the co-editor of several Journal Supplements and has published over 400 hundred scientific papers in journals like Lancet, Nature, Human Reproduction Update, Human Reproduction, Fertility and Sterility, etc. His current Hirsch index (h-index) is 63 while his citation count is over 12K. He is a member of ‘Faculty Opinions’ in the area of reproductive endocrinology & infertility. Dr. Esteves is Associate Editor of Frontiers in Endocrinology (Reproduction), Andrology, International Brazilian Journal of Urology, Regional Editor of the Société Internationale d’Urologie Journal, an editorial board member of Nature Reviews Urology, and a dozen of other peer-reviewed scientific journals. He is also a co-founder of the POSEIDON group and currently serves as a Chair of the Male Infertility Section of the WHO Infertility Guidelines Development Group.

Dr. Esteves is a very much requested speaker and presents over 50 lectures annually. He also regularly conducts infertility workshops, provides consulting services in the area of quality management for ART Clinics,

· Robert Fischer ·

Robert Fischer is the founder and Medical Director of the Fertility Center Hamburg (FCH) in Hamburg, Germany. Dr Fischer trained in obstetrics and gynaecology at the University Hospital of Münster, Germany, from 1979 to 1982 and at the Queen’s Medical Centre, University of Nottingham, UK. In 1983, Dr Fischer pioneered the first German outpatient IVF unit in Hamburg and became its Medical Director. The unit moved to a new location in 1998, and its name was changed to the “Fertility Center Hamburg”.

In July 1998, the Fertility Center Hamburg was one of the first centres, both in Germany and worldwide, to introduce quality management, and it was certified according to the ISO 9001 and accredited for IVF laboratories (ISO 17025). Dr Fischer’s main research interests are in the development of stimulation protocols, luteinizing hormone supplementation, and gonadotropin-releasing hormone agonist triggering, as well as further development of quality management systems in IVF centres. He is a founding member of the European Society of Human Reproduction and Embryology (ESHRE); a founding member of the POSEIDON (Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number) group);  Member of the  Scientific Committee of Excellence in Medical Education (EXCEMED- formerly the Serono Symposia International Foundation) and Scientific director of  Med.E.A.( Medical Education Academy)

· Peter Humaidan ·

Professor Peter Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, use of GnRH antagonists, and OHSS prevention. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” and co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient. Moreover, he is a past board member of the ESHRE SIG Endocrinology Group. He authored and co-authored 187 + articles (H-index 44, Google Scholar) in international peer reviewed journals as well as the Danish guidelines for OHSS prevention and chapters in textbooks. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences.

· Pedro Xavier ·

Pedro Xavier, MD., Ph.D. is a specialist in Reproductive Medicine with over 20 years of clinical experience in the field of reproductive medicine, with a special interest in endometriosis as well as in laparoscopic surgery applied to the treatment of infertility. He led the team at São João Hospital, Porto, Portugal, that in 2015 performed the first ovarian tissue transplant in his country.

He earned his MD degree in 1992, from the Faculty of Medicine of the University of Porto, Portugal; he specialized in obstetrics and gynaecology in 2001, and gained a PhD in 2005, from the same university. His doctoral thesis explored the endometrial characteristics in patients with endometriosis. 

Pedro Xavier is now the President of the Portuguese Society of Reproductive Medicine and member of the National Council for Medically Assisted Reproduction.

He authored and co-authored several articles in international peer reviewed journals in the field of reproductive medicine and has been invited to lecture at national and international meetings dealing with reproductive medicine and gynaecological endocrinology; he has also served as a reviewer for international journals in these fields.

· Claus Yding Andersen ·

Claus Yding Andersen is Scientific Director of Laboratory of Reproductive Biology, University Hospital of Copenhagen, Denmark and Professor of Human Reproductive Physiology within the Faculty of Health and Medical Sciences at the University of Copenhagen.  He is educated as MSc (1979) and DMSc (1997).

Professor Andersen was a member of the team that introduced IVF to Denmark in the mid-1980s, is senior accredited ESHRE embryologist and have worked as a consultant in more 10 fertility clinics nationally and internationally. During the last fifteen years he has headed a national program of cryopreservation of human ovarian and testicular tissue, which is approved by the Danish Authorities. He is considered one of the pioneers in this field and continue to expand the indications for the use of ovarian tissue cryopreservation in different clinical settings.

Professor Andersen’s major research contributions have been in ovarian endocrinology, oocyte maturation, cryopreservation of gonadal tissue, human embryonic stem cells and development of new principles for ovarian stimulation including the introduction of the agonist trigger and novel approaches to luteal phase support.

He has published more than 300 peer-reviewed scientific papers plus 9 patents. He is a much-requested international lecturer and is currently giving 20-30 international lectures annually. His current H-index is 60 and has received almost 12.000 citations (Google Scholar).

He has served on the editorial board on five international journals and has reviewed papers for more than 25 international journals and six national research councils. His is currently chief editor on the Reproduction section in Frontiers in Endocrinology.

· Klaus Bühler ·

Klaus Bühler is a specialist in reproductive medicine working in the Centre for Reproductive Medicine and Gynaecological Endocrinology in Stuttgart, Germany, and for the Endometriosis – Centre of the University Hospitals of Saarland – Frauen rzte am Staden – in Saarbrücken. He specialized in Obstetrics and Gynaecology at the University of Tübingen where he also worked as a Senior Assistant until 1986. He furthermore operated as Assistant medical director at the University of Essen with special field of engagement in gynaecological endocrinology and reproductive medicine.

In addition to his clinical work, Dr. Bühler is Vice-Chairman of the German Scientific Endometriosis Research Foundation (SEF) and President of the German Dachverband for Biology and Medicine of Reproduction (peak-organisation of all scientific societies engaged in the field of reproductive medicine in Germany). He is also a member of the board of the European Society of Obstetrics and Gynaecology of German-French languages.

Since more than 20 years he is engaged in the National German IVF-Registry (Deutsches IVF-Register – DIR), the oldest IVF-registry and actually greatest with more than 1.5 million electronically documented treatment cycles. Dr. Bühler was the chairman from 2007 up to 2014. He has also participated in several national and international symposia and workshops in the field of Reproductive Medicine. He published more than 100 scientific papers and book contributions.

He is honorary member of the Societ  Italiana di Medicina Perinatale and in 1989 he received the Research Award of the German Endometriosis Research Foundation.

· Alessandro Conforti ·

Alessandro Conforti obtained his MD degree in 2009 and in 2010 he was a Clinical Visitor at IVF at Hammersmith Hospital, London UK directed by Mr Stuart Lavery.
During his specialization training, he worked in the Minimally Invasive Therapy Unit & Endoscopy Training Center at the Royal Free Hospital as Clinical Research Fellow under the guidance of Mr Adam Magos, Consultant Gynaecologist, from 2012 to 2013.
 
During this period, he worked as Clinical Research Fellow in the Fetal Medicine Unit under the guidance of Mr Demetrios Economides, Head of the Fetal Medicine Unit, at the Royal Free Hospital, London.
 
He acquired his specialty in Obstetrics and Gynaecology in 2015. In 2017, he obtained his PhD from the University of Naples “Federico II” with a thesis in Neuroscience and Reproductive Medicine devoted to the role of genetic variants of gonadotropins and their receptors in controlled ovarian stimulation.
 
From 2019, he is assistant professor in Obstetric and Gynecology at University of Naples Federico II. Dr Conforti research interests focus on Minimally Invasive and Reproductive Gynecological Surgery, Reproductive Medicine, Reproductive genetics, ART and Oncofertility. He has served as ad hoc reviewer for many international journals and was author or co-author of several articles published in international peer-reviewed journals.

· Michael H. Dahan ·

Michael Dahan is currently an assistant professor in the Department of Obstetrics and Gynecology at McGill University in Montreal, QC, Canada. He graduated from medical school at the State University of New York, NY, USA, at Stonybrook in 1996, following this with a residency in obstetrics and gynecology at Long Island College Hospital in New York from 1996 to 2000. He completed a fellowship in reproductive endocrinology and infertility at the University of California at San Diego, CA, USA, in 2003. After completing his fellowship, Dr Dahan was on faculty at Washington University in St. Louis MO, and Stanford University, CA, USA. He is a fellow of the American College of Obstetrics and Gynecology and the Royal College of Surgeons of Canada, Obstetrics and Gynecology Division. He is board certified by the American Board of Obstetrics and Gynecology in obstetrics and gynecology and in reproductive endocrinology and infertility.

His areas of expertise include in vitro fertilization (IVF), in-vitro maturation of eggs, egg freezing, polycystic ovary syndrome, endometriosis, male infertility, recurrent pregnancy loss, fertility preservation for cancer patients, tubal factor infertility, ovulation induction, and sperm insemination, egg donors, decreased ovarian reserve, improving outcomes in repetitive IVF failures and factors affecting menstrual periods. Dr. Dahan is a world-renowned specialist in infertility in Jewish couples, having developed and published many of the treatments specific to this population.

Dr. Dahan has authored over 196 peer-reviewed publications and 200 abstracts and has been awarded over $1.3 million in research grants. He is a past Chair of the Associate Committee of the Society for Reproductive Endocrinology and Infertility (SREI). He is currently or has been in the past on the editorial board of 9 peer-reviewed journals and He is the Editor and Chief of the Journal Clinical and Experimental Obstetrics and Gynecology. He is the editor of the next textbook on fertility care to be released by Elsevier. He has been invited to present nationally and internationally over 140 times. He was the 2008 recipient of the R. Howard Webster Award, given by the Research Institute of McGill University. He is listed in Who is Who of Medicine.

The name Dahan’s syndrome has been applied to pituitary injury due to vasospasm, which I first described in the medical literature. I performed what we believe to be the world-record oocyte retrieval of 126 eggs in a woman undergoing in-vitro maturation without ovarian stimulation.

· Joaquín Llacer ·

Dr. Llácer has over 30 years of experience in the field of assisted reproduction. He holds a Degree in Medicine and Surgery from the University of Valencia, specializing in obstetrics and gynecology at Hospital Universitario La Fe (Valencia) and holds a PhD in Medicine from the University Miguel Hernández of Elche. During the past 26 years Dr. Llácer has been part of the team of gynecologists at Instituto Bernabéu, where he also took part in the medical direction of the group and was a member of the Board of Directors.   

Among his professional achievements it was particularly noteworthy the extraordinary doctorate award for his thesis, as well has being awarded by the British Fertility Society and the American Society for Reproductive Medicine. In addition, Dr. Llácer has combined his medical activity with academic teaching in different master’s degree at University Complutense of Madrid and University of Alicante. He has authored over 50 papers in reproductive medicine journals, both national and international, and is currently a member of the scientific committee of the Spanish Fertility Society (SEF).

· Antonio La Marca ·

Antonio La Marca is Professor of Obstetrics and Gynecology at the Mother-Infant Department of the University of Modena and Reggio Emilia, Italy and he is the Medical Director of Clinica Eugin, Modena, Italy. He graduated in Medicine and Surgery at the University of Siena in 1996, specializing in Obstetrics and Gynaecology at the same institution in 2001. In 2006 he obtained a PhD, again at the University of Siena. He has been working at the Institute of Gynaecology and Obstetrics of the University Hospital of Modena since 2003. His clinical activity covers all the field of Reproductive Medicine and Surgery and has taken part in thousands of IVF cycles, laparoscopic and hysteroscopic surgical procedures. Present scientific interests include: ovarian reserve and pharmacological manipulation of ovarian activity. His most impactful articles concerned the physiological significance of AMH and AFC, their measurement and clinical utility. Moreover, he has published a long list of original articles dealing with the prediction of ovarian reserve and response in IVF and the personalization of ovarian stimulation protocols. He is author or coauthor of 128 articles published in peerreviewed journals and authored many 26 Antonio La Marca University of Modena and Reggio Emilia and Clinica Eugin Modena, Italy chapters in national and international textbooks. He has been an Invited speaker in more than 100 international congresses. He is involved in several phase three and four trials as Principal Investigator and is the recipient of many competitively assigned research funds. He is an active member of many national and international professional and scientific societies and a consultant for the Italian Ministry of Health for female fertility-related issues.

· Habib Midassi ·

Assistant professor of obstetrics and gynecology,Sfax university.Tunisia.(1987)

Mr Habib has completed his higher accreditation in Obstetrics and Gynecology in 1986

He works six years  as a consultant  in the Sfax teatching hospital .in 1988 he has his private office of gynecology and obstetrics.Since 2007 he also works in the IVF  center  of the polyclinic Ibn Annafis ,Sfax.Tunisia.

He has a wide experience in treating infertile couple with the first specialized fertility consultation in Tunisia (1984) .

Besides laparoscopic  Surgery, his professional interests include ovarian reserve ,luteal phase support and medical treatement of uterine fibroids

· Maria G. Minasi ·

Biological degree, 1993; Master in Reproductive Medicine, 2011; Master in Dietetics and Nutrition, 2019. 1994-1997: embryologist in several laboratories of Rome, Italy. 1998-2000: researcher, stem cells project, Dep Histology-Embriology, Rome University. From 2001 to 2021 embryologist and from 2009 to 2021 lab director for the Centers for Reproductive Medicine of European Hospital and Villa Mafalda, Rome. Founder of the individual company “Lavitaminasi”. Embryologist and nutritionist consultant in several Italian centers. Consultant for nutrigenetics of the Eurofins Genoma group. Professor at masters in Human Applied Embryology, Roma Tre University, Rome, and in Biology of Nutrition for Human Reproduction, La Sapienza University, Rome. Senior Clinical Embryologist from 2013. Member of Executive Committee of SIERR (2016-2019) and of SIRU (2021-ongoing). Top reviewer for Human Reproduction (2017).  Associate Editor for Human Reproduction from 2022. More than 80 studies published in international journals and more than 100 communications to national and international congresses.

· Raoul Orvieto ·

Raoul Orvieto is Professor of Obstetrics and Gynecology and incumbent of the Tarnesby- Tarnowski Chair for Family Planning and Fertility Regulation at the Sackler Faculty of Medicine, Tel Aviv University, Israel. Professor Orvieto is also Director of the Division of Reproductive Endocrinology and Infertility at the Sheba Medical Center Hospital – Tel Hashomer in Ramat Gan, Israel. Professor Orvieto’s scientific interests include: various aspects of controlled ovarian hyperstimulation (COH); the role of gonadotropin-releasing hormone (GnRH) analogues, and specifically GnRH agonist versus antagonist in COH for in vitro fertilization; preimplantation genetic screening; and triggering final follicular maturation. He also focuses on several aspects of ovarian hyperstimulation syndrome: pathophysiology, prediction, prevention, and its relation to the inflammatory response. Professor Orvieto is Co-Editor-in-Chief of Reproductive Biology and Endocrinology (impact factor 2.849). He has also authored or co-authored more than 300 publications in national and international journals.

· Nina Papathanasopoulou ·

Nina Papathanasopoulou joined the Classics faculty at College Year in Athens in January 2020. She specializes in Greek drama, mythology, and its reception. Her dissertation and early research focused on Aristophanes and his treatment of space, while her current research explores interpretations of Greek myths by the American dancer and choreographer, Martha Graham. She has published on Martha Graham’s reimagining of the myths of Medea and Ariadne and is currently working on Night Journey, Graham’s take on the myth of Oedipus. Nina completed her PhD in Classics at Columbia University in 2013 and her BA in Classics at the National and Kapodistrian University of Athens in 2003. From 2013 to 2019 she was Visiting Assistant Professor of Classics at Connecticut College, where she taught Greek, Latin, Classics and Theater courses and was heavily involved in outreach programming for Classics. At Connecticut College she also served as academic advisor both for first-year students navigating their transition to college and for Classics majors.

Since January 2019 she also works as the Public Engagement Coordinator for the Society for Classical Studies, where she oversees their new initiative, “Ancient Worlds, Modern Communities” (formerly Classics Everywhere). “Ancient Worlds, Modern Communities” encourages interdisciplinary collaborations between Classics and other fields and supports programs that engage individuals, groups, and communities in critical discussion of and creative expression related to the ancient Mediterranean. Nina writes monthly posts for the SCS blog about the programs the initiative supports.

Using her passion and enthusiasm for the material and for the dynamics of education, Nina strives to spark her students’ curiosity and desire for learning. She believes that studying the Ancient Greeks – their literature and culture – can help us understand human nature and human difference, gain a deeper appreciation of ourselves and others, and think deeply about the way we operate and co-exist with others. In class she tries to create a comfortable environment where students are encouraged to voice their opinions freely, while fostering intellectual rigor and creativity

· Valerie Peddie ·

I have been involved in Fertility Nursing since 1993 and chaired of the Royal College of Nursing (RCN) Midwifery & Fertility Nurses Forum from 2008-2011. I currently hold the position of Nurse Consultant, Fertility Preservation (NHS Grampian), member of the European Society of Human Reproduction & Embryology (ESHRE) Nurses & Midwives Certification Committee and Editorial Board (Human Fertility) in addition to peer reviewer for several fertility and oncology related journals. Overall, I have a specialist interest in exploring reproductive potential and decision-making within a variety of settings – including oncology – contributing to the RCN clinical professional resource ‘Fertility Preservation’ (2017). I have designed analysed and published numerous applied qualitative and clinical studies in reproductive health care, written several book chapters, and continue to support the Robert Gordon University, Aberdeen in providing teaching sessions in Fertility and Reproduction for 3rd Year Midwifery Students.
MSc; BA (Hons); ADM; RM; RGN

· Filippo Maria Ubaldi ·

Filippo Maria Ubaldi is Medical Doctor, Clinical Director at the GENERA Centres for Reproductive Medicine in Rome, Marostica, Umbertide and Naples, Italy. With academic degrees in Obstetrics and Gynaecology, Masters in Andrology and Reproductive Medicine, PhD at the Vrije Universiteit Brussel in Andrology and Reproductive Medicine, he is also intensely dedicated to educational, editorial and practitioner activities.
Co-author of 10 books on the topic of Reproductive Medicine, author and co-author of 146 scientific papers of which 131 are peer reviewed journals (PubMed 01/12/2018); author H-index is 43. Editor of the treaty on Reproductive Medicine ‘Medicina della Riproduzione Umana’ published in Italy in 2010. Invited as speaker at 422 National and International congresses on the topic of Reproductive Medicine and has been Scientific Coordinator of 74 congresses and courses. Member of the ESHRE Executive Committee during 2005-2009, he has been Chairman of the 26th ESHRE Annual Meeting held in Rome in June 2010. In 2014 he received the Italian National Scientific License as full Professor in Obstetrics and Gynaecology and between 2014-2015 has been member of the technical advisory board established by the Ministry of Health on heterologous fertilization.

· Margarida Silvestre ·

Margarida Silvestre is a medical doctor, specialist in Obstetrics-Gynecology and Subspecialist in Reproductive Medicine by the Portuguese Medical Association and has a PhD Degree in Bioethics, from the Portuguese Catholic University, Portugal. She is Professor of Medical Ethics and Deontology, at the Faculty of Medicine, University of Coimbra, Portugal. She is founder and partner of CLINIMER – Reproductive Medicine Clinic (Coimbra, Portugal), where she also works as clinician. Currently holds the following positions:
1. Member of the National Council of Ethics for the Life Sciences, elected by the Portuguese Parliament.
2. Chairman of the Ethics Committee of the Faculty of Medicine of the University of Coimbra.
3. Senior Deputy of the SIG Ethics and Law Steering Committee of the European Society of Human Reproduction and Embryology.
4. Member of the Board of the Republic of Law – Coimbra Legal Association.
5. Vice-Chairman of the Portuguese Society for Reproductive Medicine.
6. Member of the National Council of Ethics and Medical Deontology of the Portuguese Medical Association.
7. Coordinator of the Ethics and Deontology Office of the Regional Center Section of the Medical Association.
8. Member of the Board of Reproductive Medicine of the Portuguese Medical Association.
9. Founding member of Red tica – National Network of Ethics Committees for Health.

· Sesh K. Sunkara ·

Sesh Sunkara is a Senior Clinical Lecturer in Reproductive Medicine at King’s College London. She is a Subspecialist in Reproductive Medicine and Surgery having initially specialised in general Obstetrics and Gynaecology. She is a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG), UK. Her research work on poor responders undergoing IVF formed the basis for her thesis leading to her Research degree in Reproductive Medicine; Doctor of Medicine (MD) awarded by King’s College London. She has dual accreditation with the UK General Medical Council as a Specialist in Obstetrics and Gynaecology as well as a Subspecialist in Reproductive Medicine. She worked as a Consultant gynaecologist and Subspecialist in Reproductive Medicine at the Aberdeen Fertility Centre, University of Aberdeen and then moved to Queens Hospital, Barking Havering and Redbridge University Hospitals, Essex UK to set up and leads the IVF service.
In addition to her clinical work, Dr Sunkara has published over 50 PubMed indexed peer reviewed research papers and authored several book chapters in the field of Reproductive Medicine. She is currently Associate Editor for Human Reproduction Update Journal was previously Associate Editor of the Human Reproduction Journal from 2014 to 2018. She is on the Editorial Board of Reproductive Biology and Endocrinology and Associate Editor of Gynecologic and Obstetric Investigation Journals. She has organized several national and international symposia and workshops.
Dr Sunkara is a member of the ESHRE Guideline Development Group (GDG) for Ovarian Stimulation in IVF and upcoming ESHRE Guideline on Unexplained Infertility. She is Deputy Chair for the RCOG Reproductive Medicine Clinical Studies Group (2015 -current), which is actively involved in supporting multicenter research studies in the UK.

· Budi Wiweko ·

Budi Wiweko, SpOG(K), MPH He is The Immediate Past President of Asia Pacific Initiative on Reproduction (ASPIRE) for 2018 – 2021 and also a vice director of Indonesian Medical Education and Research Institute Faculty of Medicine Universitas Indonesia (IMERI FKUI). Currently he is a general secretary of Asian Society for Fertility Preservation (ASFP), an organization who establish fertility preservation in Asian Region. In Indonesia He serves as The President of Indonesian Association for IVF (IA-IVF) for 2016-2021 and a current General Secretary for Indonesian Society for Obstetrics and Gynecology (POGI). He is also the chairman of International Relationship Affair of Indonesian Medical Association (IMA). He just appointed as a chairman of Indonesia Health Technology Assessment Committee Ministry of Health Republic of Indonesia and a member of Indonesia National Academic of Sciences in 2020. After graduated as a specialist in Obstetrics and Gynecology from Universitas Indonesia in 2005, he spent his time as a research fellow on ovarian tissue vitrification and in vitro culture of follicles at Hyogo College of Medicine Japan. He continued his research on basic laboratory on ART and had some clinical IVF training in Osaka, Barcelona, Thailand and Vietnam. He defended his PhD thesis on “Pre-antral follicle vitrification” in Faculty of Medicine Universitas Indonesia in 2014. Then he continued study to received master’s degree in public health from University of Gadjah Mada – Yogyakarta, Indonesia. He is a former research manager FKUI (2014-2018) who contribute a lot for establishing research and innovation in FKUI as well as IMERI development. He did also a lot of contribution in developing IVF field in Indonesia since he is one of the founders of Indonesian Association for In Vitro Fertilization (IA-IVF) which was founded in 2009. Instead of giving services, he is also a coordinator of trainer for Subspecialty in Reproductive Endocrinology and Infertility Fellowship which is underwent in Teaching Hospital Universitas Indonesia. His researches about AMH, iCOS, and ovarian tissue vitrification were published in local journal and international journal and also conference of ART such as ASPIRE, ESHRE and IFFS annual meeting. Up to now, he has published 110 original articles in international journal indexed in Scopus and 38 original articles indexed in Pub-Med, with h – index 10. He has received a lot of awards nationally and internationally, including Best Graduates Awards from FKUI 2005, Best Indonesian young obstetrics and gynecologist award 2005 (Tadjuludin Award), Asia Pacific Young Gynecologist Award 2007, Indonesian Best Paper Award 2009 (Sarwono Awards) Best researcher FKUI 2009, 2010, 2011, Asia Pacific Best Paper 2014, First Winner of Universitas Indonesia Best Lecturer 2015, First Winner of Indonesian Best Lecturer 2015, UI Innovation Award, Gynecologist innovation awards 2015 (Makelew Award), Indonesian Best Paper Awards 2009 (Sarwono Awards), Best Indonesian Innovator 2016 (First place and second place of Inovation 2016). His newest innovation was selected as 112 Indonesian Best Innovation 2020. He did and published a lot of researches in ART especially in AMH, individualized controlled ovarian stimulation (iCOS), ovarian tissue vitrification and embryo metabolomics. He is the one of AMH expert in Asian region since he developed AMH nomogram and AMH based iCOS formula which is very important for daily practice on infertility. His product Indonesia Kalkulator Oocytes (IKO) was patented and registered on play store and apple store, was use across the globes. Currently he is a member of advisory board of Merck Serono Asia Pacific and very active in a lot of regional organization such as Pacific Rim Fertility Society (PRFS), European Society for Human Reproduction and Embryology (ESHRE), International Federation of Fertility Society (IFFS), American Society for Reproductive Medicine (ASRM), International Society for Fertility Preservation (ISFP) and American Association for Gynecology Laparoscopy (AAGL). Now he is trying to develop ovarian tissue cryopreservation in Indonesia and establish Asian Society of Fertility Preservation (ASFP) as founding member.

· Hakan Yarali ·

Professor Hakan Yaralı, MD is the Clinical Director of Anatolia IVF Center and Professor at Hacettepe University, Ankara, Turkey. Following medical school and residency training in OB/GYN at Hacettepe University, Hakan Yaralı did his clinical fellowship at University of British Columbia, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Vancouver, Canada during 1991-1992. He has authored more than 120 articles, eight book chapters and delivered over 50 lectures worldwide. He has roles as a reviewer in top-ranked journals. He was the former president of Turkish Society of Reproductive Medicine (TSRM). He has organized several national, international meetings and preceptorship programs training clinicians from diverse countries. He is directing Anatolia IVF, which is one of the busiest IVF centers in Turkey, performing over 1600 cycles annually. His special interests are clinical IVF-all aspects.